Doxirobe

RSS
Withdrawn

This medicine's authorisation has been withdrawn

doxycycline
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Doxirobe has not been renewed by the marketing authorisation holder and is now withdrawn.

Product information

01/12/2003

Product details

Name of medicine
Doxirobe
Active substance
doxycycline
International non-proprietary name (INN) or common name
doxycycline
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QJ01AA02

Pharmacotherapeutic group

Antibacterials for systemic use

Therapeutic indication

Treatment of periodontal disease in dogs.
Periodontal pocket probing depths >=4 mm are evidence of disease that may be responsive to treatment with the Doxirobe Gel. Use of this product as directed should result in attachment level gains, periodontal pocket depth reductions, local antimicrobial effect and improved gingival health. Noticeable improvements in these parameters should be evident within 2-4 weeks following treatment. The response in individual dogs is dependent on the severity of the condition and rigor of adjunctive therapy.

Authorisation details

EMA product number
EMEA/V/C/000044
Marketing authorisation holder
Pfizer Limited

Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom

Marketing authorisation issued
16/09/1999
Revision
4
This page was last updated on

Share this page